Ramosetron on Late PONV (Postoperative Nausea and Vomiting)

Summary

The purpose of this study was to evaluate the effectiveness of additional ramosetron injection for controlling late postoperative nausea and vomiting (PONV) after breast surgery in high risk PONV patients. The investigators compared PONV amomng 3 groups- group C: no additional ramosteron, group B: two additional ramosteron doses at 12 hour interval, group M: two additional ramosetron doses mix to the intraveonus patient controlled analgesia.

Timeline

Start

2020-12-17

Primary completion

2021-10-31

Completion

2021-10-31

Drugs

Indications